Work

iRGD in combination with IL-2 reprograms tumor immunosuppression.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.8_suppl.55

Authors: Gregory P. Botta, Tatiana Hurtado De Mendoza, Harri Jarvelainen, Erkki Ruoslahti

Institution: Sanford Burnham Prebys Medical Discovery Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2960238132

Cites:

Cited by: 3

Related to: 10